The post Safe-haven assets remain in demand as Middle East crisis widens appeared on BitcoinEthereumNews.com. Here is what you need to know on Thursday, March 5The post Safe-haven assets remain in demand as Middle East crisis widens appeared on BitcoinEthereumNews.com. Here is what you need to know on Thursday, March 5

Safe-haven assets remain in demand as Middle East crisis widens

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Here is what you need to know on Thursday, March 5:

Financial markets remain risk-averse in the second half of the week as the conflict in the Middle East widens. The US economic calendar will feature mid-tier macroeconomic data releases, while investors will remain focused on geopolitical headlines.

A US submarine sunk an Iranian warship off the coast of Sri Lanka on Wednesday and NATO air defense systems shot down an Iranian missle heading toward Turkiye’s airspace. Meanwhile, the US Senate rejected a a resolution that is designed to force US President Donald Trump to seek congressional approval for further military action against Iran. CNN reported that a top US official said that the US will start attacking deeper into Iran, noting that the operation is still in its early days.

Crude oil prices rise for the fourth consecutive day on Thursday. At the time of press, the barrel of West Texas Intermediate was trading at $77.15, rising about 1.4% on the day.

Following a two-day rally, the US Dollar (USD) Index corrected lower and closed in negative territory on Wednesday. The USD Index regains its traction and fluctuates above 99.00 early Thursday, rising about 0.3% on the day. The data from the US showed on Wednesday that the Institue for Supply Management (ISM) Services Purchasing Managers’ Index (PMI) improved to 56.1 in February from 53.8 in January. Additionally, Automatic Data Processing’s (ADP) Employment Change for February came in at 63K, surpassing the market expectation of 50K. Later in the day, the US Department of Labor will publish the weekly Initial Jobless Claims data.

US Dollar Price This week

The table below shows the percentage change of US Dollar (USD) against listed major currencies this week. US Dollar was the strongest against the Swiss Franc.

USD EUR GBP JPY CAD AUD NZD CHF
USD 1.56% 0.74% 0.85% 0.17% 0.50% 0.79% 1.80%
EUR -1.56% -0.82% -0.73% -1.37% -1.04% -0.75% 0.24%
GBP -0.74% 0.82% -0.10% -0.56% -0.24% 0.06% 1.06%
JPY -0.85% 0.73% 0.10% -0.63% -0.28% 0.06% 0.99%
CAD -0.17% 1.37% 0.56% 0.63% 0.31% 0.70% 1.63%
AUD -0.50% 1.04% 0.24% 0.28% -0.31% 0.29% 1.30%
NZD -0.79% 0.75% -0.06% -0.06% -0.70% -0.29% 1.00%
CHF -1.80% -0.24% -1.06% -0.99% -1.63% -1.30% -1.00%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the US Dollar from the left column and move along the horizontal line to the Japanese Yen, the percentage change displayed in the box will represent USD (base)/JPY (quote).

After suffering large losses on Tuesday, Gold (XAU/USD) found support and registered marginal gains on Wednesday. XAU/USD stays relativley quiet in the European morning on Thursday and fluctuates above $5,150.

EUR/USD snapped a two-day losing streak on Wednesday but failed to preserve its recovery momentum on Thursday. The pair edges lower in the early European session and trades near 1.1600.

GBP/USD turns south on Thursday and declines toward 1.3300, pressured by the renewed USD strength.

USD/JPY rebounds following the bearish action seen in the early Asian session and trades in positive territory above 157.00.

WTI Oil FAQs

WTI Oil is a type of Crude Oil sold on international markets. The WTI stands for West Texas Intermediate, one of three major types including Brent and Dubai Crude. WTI is also referred to as “light” and “sweet” because of its relatively low gravity and sulfur content respectively. It is considered a high quality Oil that is easily refined. It is sourced in the United States and distributed via the Cushing hub, which is considered “The Pipeline Crossroads of the World”. It is a benchmark for the Oil market and WTI price is frequently quoted in the media.

Like all assets, supply and demand are the key drivers of WTI Oil price. As such, global growth can be a driver of increased demand and vice versa for weak global growth. Political instability, wars, and sanctions can disrupt supply and impact prices. The decisions of OPEC, a group of major Oil-producing countries, is another key driver of price. The value of the US Dollar influences the price of WTI Crude Oil, since Oil is predominantly traded in US Dollars, thus a weaker US Dollar can make Oil more affordable and vice versa.

The weekly Oil inventory reports published by the American Petroleum Institute (API) and the Energy Information Agency (EIA) impact the price of WTI Oil. Changes in inventories reflect fluctuating supply and demand. If the data shows a drop in inventories it can indicate increased demand, pushing up Oil price. Higher inventories can reflect increased supply, pushing down prices. API’s report is published every Tuesday and EIA’s the day after. Their results are usually similar, falling within 1% of each other 75% of the time. The EIA data is considered more reliable, since it is a government agency.

OPEC (Organization of the Petroleum Exporting Countries) is a group of 12 Oil-producing nations who collectively decide production quotas for member countries at twice-yearly meetings. Their decisions often impact WTI Oil prices. When OPEC decides to lower quotas, it can tighten supply, pushing up Oil prices. When OPEC increases production, it has the opposite effect. OPEC+ refers to an expanded group that includes ten extra non-OPEC members, the most notable of which is Russia.

Source: https://www.fxstreet.com/news/forex-today-safe-haven-assets-remain-in-demand-as-middle-east-crisis-widens-202603050827

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09